Correction: Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States
Clostridium difficile and Clostridium perfringens research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Correction: Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States
Yoav Golan, Alpesh Amin, Dianne Nguyen, Michele Wilson et al.
Journal
Infectious Diseases and Therapy
Topics
Clostridium difficile and Clostridium perfringens research
article
Correction: Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States
Tufts Medical Center (US), University of California, Irvine (US), Nestlé (Switzerland) (CH), RTI Health Solutions (US), Nestlé Health Science (United States)
OpenAlex Percentile
Openalex Percentile: Top 59%
Topics
Clostridium difficile and Clostridium perfringens research